Skip to Content

Orpea SA ORPEF Stock Quote

| Rating as of


Morningstar‘s Stock Analysis ORPEF

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics ORPEF

Company Profile ORPEF

Business Description

Orpea SA operates a network of long-term, post-acute, psychiatric, and home care facilities in Europe. The majority of the firm's revenue is generated in France. Orpea's long-term care facilities are primarily nursing homes, though it also provides serviced residences for autonomous and semi-autonomous elderly patients. Orpea's post-acute and rehabilitation facilities specialize in geriatrics, musculoskeletal conditions, cardiovascular conditions, nervous system diseases, and, Haematology and oncology. Its psychiatric clinics provide treatment and psychotherapeutic monitoring for a range of conditions.

12, Rue Jean Jaures, CS 10032
Paris, 92 813, France
T +33 147757807
Industry Medical Care Facilities
Most Recent Earnings
Fiscal Year End Dec 31, 2022
Employees 12,424